SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-013619
Filing Date
2018-05-15
Accepted
2018-05-15 16:00:30
Documents
11
Period of Report
2018-05-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acer-8k_20180514.htm 8-K 111403
2 EX-2.1 acer-ex21_12.htm EX-2.1 416397
3 EX-3.1 acer-ex31_11.htm EX-3.1 19960
4 EX-3.2 acer-ex32_10.htm EX-3.2 12895
5 EX-3.3 acer-ex33_8.htm EX-3.3 32478
6 EX-3.4 acer-ex34_9.htm EX-3.4 213205
7 EX-3.5 acer-ex35_6.htm EX-3.5 17557
8 EX-4.1 acer-ex41_13.htm EX-4.1 5716
9 EX-10.3 acer-ex103_7.htm EX-10.3 84752
10 GRAPHIC g201805151241328925187.jpg GRAPHIC 59217
11 GRAPHIC g201805151241328665186.jpg GRAPHIC 104735
  Complete submission text file 0001564590-18-013619.txt   1142276
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 18836130
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1